Last reviewed · How we verify

NCT03356548: HEMOSAT

Transferrin Saturation and Asthenia in Hemochromatosis

Completed Last updated 31 July 2019
What this trial tests

trial in Hemochromatoses, Genetic in 260 participants. Completed in 9 April 2019.

Timeline
10 April 2017
Primary endpoint
9 April 2019
9 April 2019

Quick facts

Lead sponsorRennes University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment260
Start date10 April 2017
Primary completion9 April 2019
Estimated completion9 April 2019
Sites1 location across France

Conditions studied

Sponsor

Rennes University Hospital

Who can join

18 and older, any sex, with Hemochromatoses, Genetic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Observational study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Rennes University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03356548.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing